Rhenman & Partners Asset Management AB - BIND THERAPEUTICS INC ownership

BIND THERAPEUTICS INC's ticker is BINDQXXXX and the CUSIP is 05548N107. A total of 22 filers reported holding BIND THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is 0.01 and the average weighting 0.0%.

Quarter-by-quarter ownership
Rhenman & Partners Asset Management AB ownership history of BIND THERAPEUTICS INC
ValueSharesWeighting
Q1 2016$294,000
-3.9%
133,5350.0%0.06%
+26.1%
Q4 2015$306,000
-48.7%
133,5350.0%0.05%
-51.6%
Q3 2015$596,000
-20.1%
133,5350.0%0.10%
+5.6%
Q2 2015$746,000
+1.8%
133,5350.0%0.09%
-27.4%
Q1 2015$733,000
+1.7%
133,5350.0%0.12%
-40.7%
Q4 2014$721,000
-22.6%
133,535
+23.0%
0.21%
-23.4%
Q3 2014$932,000
-34.8%
108,5350.0%0.27%
-35.6%
Q2 2014$1,430,000
+99.2%
108,535
+80.9%
0.42%
+96.3%
Q1 2014$718,00060,0000.22%
Other shareholders
BIND THERAPEUTICS INC shareholders Q2 2016
NameSharesValueWeighting ↓
Opaleye Management Inc. 155,000$2,123,500,0001.67%
EMERALD MUTUAL FUND ADVISERS TRUST 604,207$8,426,0000.50%
BVF INC/IL 150,000$2,264,0000.40%
EMERALD ADVISERS, LLC 419,752$6,334,0000.34%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 256,384$3,869,0000.20%
Alyeska Investment Group, L.P. 62,087$937,0000.04%
THOMPSON DAVIS & CO., INC. 1,500$23,0000.04%
PRELUDE CAPITAL MANAGEMENT, LLC 13,000$196,0000.03%
SSI INVESTMENT MANAGEMENT LLC 23,580$356,0000.03%
TFS CAPITAL LLC 20,933$316,0000.02%
View complete list of BIND THERAPEUTICS INC shareholders